WHO
[대역어] WHO
[용어속성] Institution
[용어속성] Institution
Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
Research article
[키워드] Antiviral treatment
Care
cascade
Clinical Center
clinical centers
clinical unit
collected
comparable
conducted
country
COVID-19
COVID-19 pandemic
diagnose
Diagnosis
effort
European
evaluate
expected
expressed
Factors
Frame
HBsAg
HBV
HBV DNA
HCV
Hepatitis
hepatitis B
Hepatitis B virus
hepatitis C virus
Impact
limitation
liver
maintain
measure
pandemic
public health
questionnaire
reduction
representing
Result
RNA
target
targets
the WHO
transferred
Treatment
Viral hepatitis
WHO
WHO elimination targets
World Health Organization
[DOI] 10.1016/j.jhepr.2022.100531 [Article Type] Research article
[DOI] 10.1016/j.jhepr.2022.100531 [Article Type] Research article
Prospective two-arm study of the testicular function in patients with COVID-19
COVID-19 환자의 고환 기능에 대한 전향적 양군 연구
Clinical Trial
[키워드] Affect
Agglutination reaction
Analysis
Autopsies
Autopsy
Cell
Chest computed tomography
collected
Community
Computed tomography
Control
COVID-19
COVID-19 pandemic
COVID-19 patient
damage
died
Direct
discharge
discharge home
disorder
Effect
exhibited
follicle-stimulating hormone
Health Organization
healthy control
healthy controls
Hospital stay
human body
increase in
infiltration
Inflammation
International
Laboratory
lack
Luteinizing Hormone
majority
male
male fertility
male hormone
male reproductive system
management
MAR
material
moderate
moderate to severe
multiple organ
multiple organs
parameter
participant
Patient
patients with COVID-19
patients with moderate
positive
postmortem examination
Prospective
Prospective Study
reproductive
reproductive system
Research
returned
SARS-CoV-2
Semen
Semen analysis
severe disease
significantly
Sperm
spermatogenesis
Symptom
testes
testicle
Testosterone
the disease
the healthy
throat swab
tissue
Topic
Trial
Two-arm
Viral pneumonia
virus
was performed
WHO
World Health Organization
[DOI] 10.1111/andr.13159 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1111/andr.13159 PMC 바로가기 [Article Type] Clinical Trial
Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2
SARS-CoV-2의 필수 단백질(스파이크 단백질 및 주요 프로테아제) 억제제의 용도 변경 및 식별
Article
[키워드] Analysis
binding energy
Cefoperazone
Clinical use
Compound
Coronavirus infection
COVID-19
docked
domain
drug
effort
EGCG
Emergency
exhibited
FIVE
glycoprotein
GRN
HCQ
Hydroxychloroquine
identify
Infection
inhibitor
inhibitors
inhibitors of SARS-CoV-2
Inhibitory effects
Lopinavir
LPV
M pro
main protease enzyme
MDs
molecular
molecular docking
molecular dynamic simulations
MPro
nelfinavir
outbreak
predicted
protease
Protein
Public
public health emergency
RBD
RDV
Receptor-binding domain
recorded
Remdesivir
repurposing
SARS-CoV
SARS-CoV-2
SARS-CoV-2 spike protein
screened
spike (S) glycoprotein
Spike protein
were used
WHO
World Health Organisation
Zafirlukast
[DOI] 10.1080/07391102.2021.1886993 PMC 바로가기 [Article Type] Article
[DOI] 10.1080/07391102.2021.1886993 PMC 바로가기 [Article Type] Article
Increased burden of booster shots for COVID-19 amidst vaccine hesitancy in Pakistan
Short communication
[키워드] B.1.1.529
BNT162b2 vaccine
booster
build
Care
communication
confirmed case
counseling
COVID-19
death
effort
expected
immunized
Increased
likelihood
mutate
Mutation
Novel coronavirus
omicron
pandemic
provide
reduce
reported
significantly
the disease
two-dose regimen
vaccination
Vaccine
Vaccine hesitancy
variant
virus
WHO
World Health Organization
[DOI] 10.1016/j.amsu.2022.104360 [Article Type] Short communication
[DOI] 10.1016/j.amsu.2022.104360 [Article Type] Short communication
Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review
Article
[키워드] Abstract
activity
article
Cancer
Care
Colorectal
Colorectal cancer
Combination
compensating
country
COVID-19
COVID-19 crisis
COVID-19 pandemic
declining
decrease
disease
duplicates
effective intervention
eligible
fit
global pandemic
Health
hospital
immunochemical
Impact
Infection
investigated
lack
less
maintain
Mortality
performed
prevalence of COVID-19
prevalent
reduce
reduction in
resource
respiratory
review
Screening
selected
Surveillance
systematic review
Web of Science
were used
WHO
World Health Organization
[DOI] 10.1007/s12029-021-00679-x PMC 바로가기
[DOI] 10.1007/s12029-021-00679-x PMC 바로가기
Covid-19, an unfinished story
Mini review
[키워드] activities
acute respiratory distress
age
amplitude
bat coronavirus
Beta
Betacoronavirus
caused
China
Cluster
Comorbidities
compulsory vaccination
condition
confirmed case
coronavirus
COVID-19
Critical
cross
deaths
degree
Delta
detect
development
drug
effective
Efficacy
epidemic waves
epidemiological surveillance
evade
Face mask
FIVE
form
Gamma
Genome
genomic
Health
highly pathogenic
homogeneity
Host
Human
immune response
Immunity
incidence rate
include
Inflammatory
Innovation
intensive care
Measures
Messenger RNA
mild infection
Moderna
mRNA vaccine
multiorgan failure
nucleotides
occupancy rate
omicron
Oxygen therapy
pandemic
Patient
Pfizer-BioNTech
Pneumonia
preventing the transmission
progressed
Protective
replaced
RNA
SARS-CoV-2
SARS-CoV-2 vaccine
Sequencing
severity
syndrome
the WHO
thromboembolic complications
Vaccine
Vaccines
variant
variants
variants of concern
viral invasion
VoC
WHO
World Health Organization
[DOI] 10.1016/j.lpm.2022.104131 [Article Type] Mini review
[DOI] 10.1016/j.lpm.2022.104131 [Article Type] Mini review
A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
Review
Published on
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 변종, 비임상, 유전자 메커니즘, 임상, 진단, 치료법, 치료제,
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 변종, 비임상, 유전자 메커니즘, 임상, 진단, 치료법, 치료제,
[키워드] addition
administration
antibody
Antiviral
antiviral agent
antiviral drug
approved
cellular
combined treatment
Complex network
Complication
conditions
COVID-19
COVID-19 infection
COVID-19 vaccinations
critical COVID-19 patient
Cytokine release syndrome
Delta
determinant
effective
Efficacy
extrinsic
healthy
humoral
immune memory
immune system
immunogenicity
Immunological response
immunomodulators
immunomodulatory drug
indicate
Inflammation
Inflammatory response
intrinsic
lactoferrin
maintain
mechanisms
Medicine
monoclonal antibody
natural
Occurrence
offer
omicron
parameter
parameters
pathogen
PROTECT
reduce
relative contribution
Remdesivir
SARS-CoV-2
SARS-CoV-2 variants
Side effects
specific disease
Stage
the vaccine
tissue
tissue homeostasis
transmissible variant
Treatment
treatment trial
vaccination
Vaccine
vaccine responses
Vaccine-induced immunity
WHO
widespread
World Health Organization
[DOI] 10.1016/j.biopha.2022.113499 [Article Type] Review
[DOI] 10.1016/j.biopha.2022.113499 [Article Type] Review
SARS-CoV-2 genomic surveillance as an evidence-based infection control approach in an offshore petroleum employee population
근해 석유 직원 인구에서 증거 기반 감염 통제 접근 방식으로서의 SARS-CoV-2 게놈 감시
Article
Published on
Journal: American journal of infection control [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘,
Journal: American journal of infection control [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘,
[키워드] Analysis
approach
can be used
Cluster
concerning
contributed
COVID-19
Efficacy
epidemiological data
Epidemiology
evaluate
genomic
genomic data
Genomic surveillance
Gulf
Gulf of Mexico
Industrial
Industrial hygiene
Industrial hygienist
infecting
Infection
infection control
information
International
involved
limit
outbreak
Outbreaks
over
PCR
Phylogenetic analysis
platform
Population
Positive test
protocol
quarantine
reported
SARS-CoV-2
SARS-CoV-2 genome
SARS-CoV-2 genomes
SARS-CoV-2 genomic surveillance
sequenced
serology
Spread
suggested
Support
Surveillance
Symptom
tested
testing protocols
transmissions
variant
viral strain
Viral transmission
was used
WHO
Whole genome sequencing
[DOI] 10.1016/j.ajic.2022.05.008 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ajic.2022.05.008 PMC 바로가기 [Article Type] Article
A comprehensive review on Covid-19 Omicron (B.1.1.529) variant
Review article
[키워드] B.1.1.529
Beta
caused
Characteristics
clade
Clinical features
combating
coronavirus
Delta
Efficacy
Epidemiology
Gamma
immune evasion
Immunity
Lineage
Monoclonal antibodies(mAb)
mutate
mutations
omicron
Omicron (B.1.1.529)
Omicron variant
outbreak
Phylogeny
receptor binding domain (RBD)
Registered
South Africa
Spike protein
Till
titers
Transmission
Vaccine
variant
variants
virus
VoC
WHO
World Health Organization
Wuhan
[DOI] 10.1016/j.sjbs.2022.103372 [Article Type] Review article
[DOI] 10.1016/j.sjbs.2022.103372 [Article Type] Review article